Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|January 13, 2022
Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel diseaseDebbie S Deben, Dennis R Wong, Adriaan A van Bodegraven
Acta Neurochirurgica|July 8, 2024
Bupivacaine pleural effusion mimicking a hemothorax after a thoracoscopic microdiscectomy with epidural anesthesiaMaarten Te Dorsthorst-Maas, Yvonne L J Vissers, Nico M Grupa, et al.
Pharmacology, Biochemistry, and Behavior|December 3, 2022
iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expressionSamantha Ayoub, Johnny A Kenton, Morgane Milienne-Petiot, et al.
Metabolites|October 27, 2023
Implications of Tioguanine Dosing in IBD Patients with a TPMT DeficiencyDebbie S Deben, Luc J J Derijks, Bianca J C van den Bosch, et al.
Scientific Reports|September 22, 2022
A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patientsDebbie S Deben, Rob H Creemers, Arjan J van Adrichem, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 1, 2021
Rac1/pSTAT3 expression: A pharmacodynamic marker panel as a first step toward optimization of thiopurine therapy in inflammatory bowel disease patientsDebbie S Deben, Arjan J van Adrichem, Roosmarie Drent, et al.
Therapeutic Drug Monitoring|September 7, 2022
Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease PatientsSofia A W van Moorsel, Debbie S Deben, Rob H Creemers, et al.
British Journal of Clinical Pharmacology|August 26, 2024
Early therapeutic drug monitoring helps to identify inflammatory bowel disease patients with a high risk to fail thiopurine treatmentDebbie S Deben, Bjorn Winkens, Sofia A W van Moorsel, et al.
Alimentary Pharmacology & Therapeutics|May 17, 2019
Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapiesMelek Simsek, Debbie S Deben, Carmen S Horjus, et al.
BMJ Open|November 11, 2017
Validation of an automated delirium prediction model (DElirium MOdel (DEMO)): an observational studyCarlota Mestres Gonzalvo, Hugo A J M de Wit, Brigit P C van Oijen, et al.
Pageof 2